These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 33507235)

  • 21. Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects.
    Chen Y; Liu C; Fang Y; Chen W; Qiu J; Zhu M; Wei W; Tu J
    Biochem Pharmacol; 2024 Apr; 222():116066. PubMed ID: 38373592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel.
    Gordon OM; Terpilowski M; Dulman R; Keller MD; Burbelo PD; Cohen JI; Bollard CM; Dave H
    Pediatr Hematol Oncol; 2022 Sep; 39(6):571-579. PubMed ID: 35135442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4).
    Kaur R; Tada T; Landau NR
    mBio; 2023 Aug; 14(4):e0109023. PubMed ID: 37382452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
    Goletti D; Petrone L; Manissero D; Bertoletti A; Rao S; Ndunda N; Sette A; Nikolayevskyy V
    Clin Microbiol Infect; 2021 Dec; 27(12):1784-1789. PubMed ID: 34256141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.
    Wang C; Li Y; Kaplonek P; Gentili M; Fischinger S; Bowman KA; Sade-Feldman M; Kays KR; Regan J; Flynn JP; Goldberg MB; Hacohen N; Filbin MR; Lauffenburger DA; Alter G; Li JZ
    mBio; 2022 Aug; 13(4):e0157722. PubMed ID: 35762593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
    J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2.
    Banerjee A; Nasir JA; Budylowski P; Yip L; Aftanas P; Christie N; Ghalami A; Baid K; Raphenya AR; Hirota JA; Miller MS; McGeer AJ; Ostrowski M; Kozak RA; McArthur AG; Mossman K; Mubareka S
    Emerg Infect Dis; 2020 Sep; 26(9):2054-2063. PubMed ID: 32558639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
    Baang JH; Smith C; Mirabelli C; Valesano AL; Manthei DM; Bachman MA; Wobus CE; Adams M; Washer L; Martin ET; Lauring AS
    J Infect Dis; 2021 Jan; 223(1):23-27. PubMed ID: 33089317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
    Cesaro S; Ljungman P; Mikulska M; Hirsch HH; von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Masculano RC; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; ; Pagano L
    Leukemia; 2022 Jun; 36(6):1467-1480. PubMed ID: 35488021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
    Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
    Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    Maurin C; He Z; Mentek M; Verhoeven P; Pillet S; Bourlet T; Rogues F; Pugniet JL; Peyragrosse T; Barallon M; Perrache C; Aouimeur I; Acquart S; Ninotta S; Baud'huin M; Vabres B; Poinard S; Gain P; Thuret G
    PLoS Med; 2022 Mar; 19(3):e1003922. PubMed ID: 35231027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.